Client of a consultant lobbyist
Emergent BioSolutions Canada Inc.
- Meetings this Parliament
- 7
- With MPs
- 1
- Since Nov 2021
- 13
- Active registrations
- 1
Most recent reported meeting: Aug 20, 2026.
Lobbying by Emergent BioSolutions Canada Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Consultant In effect since Aug 8, 2026
Consultant William Shelling of Counsel Public Affairs Inc.
Consultant lobbyists
- William Shelling
- William Shelling
Institutions they may lobby: Correctional Service of Canada (CSC), Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), National Defence (DND), Prairies Economic Development Canada (PrairiesCan), Prime Minister's Office (PMO), Public Health Agency of Canada (PHAC), Public Safety Canada (PS), Public Services and Procurement Canada (PSPC), Royal Canadian Mounted Police (RCMP), Senate of Canada, Veterans Affairs Canada (VAC)
What they're lobbying on (8)Hide details
- Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget
- Discuss changes to naloxone take home program.
- Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats.
- Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
- Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
- To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
- Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility.
- Eligibility for Scientific Research and Experimental Development tax incentives.
Registration 952671-376237-7. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by William Shelling · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
-
Reported by William Shelling · Consultant
- Timothy Smith · Deputy Program manager, National Defence (DND)
- Paul Eagan · Medical Consultant, National Defence (DND)
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by William Shelling · Consultant
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats. Read more
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
-
Reported by William Shelling · Consultant
- Jibril Hussein · Senior Policy Advisor, Health Canada (HC)
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
-
Reported by William Shelling · Consultant
- Billy Morin · Member of Parliament
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
-
Reported by William Shelling · Consultant
- Jennifer Novak · Executive Director, Indigenous Services Canada (ISC)
- Blossom Leung · Policy Advisor, Indigenous Services Canada (ISC)
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
-
Reported by William Shelling · Consultant
- Jennifer Novak · Director General, Health Canada (HC)
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
-
Reported by William Shelling · Consultant
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
-
Reported by William Shelling · Consultant
- Joanna Lam · Policy and Regional Affairs Advisor, Indigenous Services Canada (ISC)
Discuss changes to naloxone take home program.
-
Reported by William Shelling · Consultant
- Joanna Lam · Policy and Regional Affairs Advisor, Indigenous Services Canada (ISC)
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
-
Reported by William Shelling · Consultant
- Matthew Trnkus · Policy advisor, Global Affairs Canada (GAC)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats.
-
Reported by William Shelling · Consultant
- Matthew Stenson · Director of the Executive Office, Public Safety Canada (PS)
DefenceGovernment ProcurementHealthIndustryNational Security/SecurityNatural ResourcesResearch and DevelopmentScience and Technology
-
Reported by William Shelling · Consultant
- Joanna Lam · Policy and Regional Affairs Advisor, Indigenous Services Canada (ISC)
Aboriginal AffairsGovernment ProcurementHealth
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.